Pay in 4 interest-free payments of $6.34 Learn more
Ships within 48 hours · Estimated delivery Oct 12 - Oct 17
pts patients
Its lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TR), which is in Phase IIb clinical trials to treat patients with biopsy-confirmed non-alcoholic steatohepatitis, as well as NAFLD
Pharmacies ran dry
Here are some expert tips: Choose a Qualified Medical Professional Always get injections from a certified doctor or trained healthcare provider
They are easy to take because they are chewy and if you have a busy lifestyle, you are less likely to forget them
Serious side effects and warnings Trulicity carries a Boxed Warning for thyroid C-cell tumors in rats, but it is unknown whether Trulicity would cause this type of cancer in humans
